Hikma Continues To Mull Potential To Go Alone On Xyrem
Royalties Due To Jazz One Factor For Hikma; ‘Balance What Works Best For Us’
Hikma’s recently installed CEO Riad Mishlawi told a packed room at the recent Jefferies 2024 London Healthcare Conference that Hikma had not reached a decision on pursuing its Xyrem ANDA product.
